Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.17
-1.1800-2.39%
Post-market: 48.200.0300+0.06%19:56 EDT
Volume:5.85M
Turnover:284.22M
Market Cap:97.43B
PE:15.40
High:49.05
Open:48.93
Low:48.17
Close:49.35
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.87
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.74%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.17
PE(LYR):12.89

Loading ...

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

GSK Oncology Portfolio Seems Underrated

Dow Jones
·
Jul 17

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Retreat From Chipmaker Stocks

MT Newswires Live
·
Jul 17

Sector Update: Healthcare

MT Newswires Live
·
Jul 17

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

TIPRANKS
·
Jul 17

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

Dow Jones
·
Jul 17

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Jul 17

GSK Will Likely Need to Book Write-down on Cough Drug Failure

Dow Jones
·
Jul 17

GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data

MT Newswires Live
·
Jul 17

Movement Alert|GSK Falls 4.42% in Pre-Market Trading, Trading at $50.41

Market Focus
·
Jul 17

GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results

TIPRANKS
·
Jul 17

GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing

TIPRANKS
·
Jul 17

GSK Rises Thursday, Outperforms Market

Dow Jones
·
Jul 17

GSK executives boost holdings via dividend-funded ADS purchases

TIPRANKS
·
Jul 16

GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight

TIPRANKS
·
Jul 16

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.
·
Jul 15

GSK Completes $10.6 Billion Acquisition of Nuvalent

MT Newswires Live
·
Jul 15

GSK Slides Tuesday, Underperforms Market

Dow Jones
·
Jul 15

GSK Executives Acquire Shares Under Routine Reward Plan

TIPRANKS
·
Jul 13

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13